Brief: Corline Biomedical Aims To Reach Positive EBIT, Cash Flow During 2026
Sept 12 (Reuters) - Corline Biomedical AB CLBIO.ST :
* UPDATES STRATEGIC PLAN
* AIMS TO REACH POSITIVE EBIT AND CASH FLOW DURING 2026
* IN NEXT 18 MONTHS CO TO FOCUS ON DELIVERY OF CHS TO
MEDICAL
DEVICE CUSTOMERS
Source text for Eikon: ID:nGNE1KrNzY
Further company coverage: CLBIO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Corline Biomedical AB
See all newsBrief: Corline Biomedical Expectes Positive EBITDA In 2027
Brief: Corline Biomedical: Canada To Grant Kardium Up To C$31.25 Mln For Manufacturing Capacity Expansion
Brief: Corline Biomedical Q2 Net Sales Amount To SEK 4.7 Million
Brief: Corline Biomedical Partner Kardium Receives Approval For Globe Pulsed Field System In Canada
Brief: Corline Biomedical Q1 Result After Financial Items At SEK -2.5 Mln